These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Estrogen inhibits cardiac hypertrophy: role of estrogen receptor-beta to inhibit calcineurin. Pedram A; Razandi M; Lubahn D; Liu J; Vannan M; Levin ER Endocrinology; 2008 Jul; 149(7):3361-9. PubMed ID: 18372323 [TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor beta maintains expression of KLF15 to prevent cardiac myocyte hypertrophy in female rodents. Hoa N; Ge L; Korach KS; Levin ER Mol Cell Endocrinol; 2018 Jul; 470():240-250. PubMed ID: 29127073 [TBL] [Abstract][Full Text] [Related]
5. Ligand-dependent activation of ER{beta} lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized spontaneously hypertensive rats. Jazbutyte V; Arias-Loza PA; Hu K; Widder J; Govindaraj V; von Poser-Klein C; Bauersachs J; Fritzemeier KH; Hegele-Hartung C; Neyses L; Ertl G; Pelzer T Cardiovasc Res; 2008 Mar; 77(4):774-81. PubMed ID: 18056768 [TBL] [Abstract][Full Text] [Related]
13. Neonatal cardiomyocyte hypertrophy induced by endothelin-1 is blocked by estradiol acting on GPER. Goncalves GK; Scalzo S; Alves AP; Agero U; Guatimosim S; Reis AM Am J Physiol Cell Physiol; 2018 Mar; 314(3):C310-C322. PubMed ID: 29167148 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice. Pellieux C; Sauthier T; Aubert JF; Brunner HR; Pedrazzini T J Hypertens; 2000 Sep; 18(9):1307-17. PubMed ID: 10994762 [TBL] [Abstract][Full Text] [Related]
15. Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II. Takayanagi T; Forrester SJ; Kawai T; Obama T; Tsuji T; Elliott KJ; Nuti E; Rossello A; Kwok HF; Scalia R; Rizzo V; Eguchi S Hypertension; 2016 Oct; 68(4):949-955. PubMed ID: 27480833 [TBL] [Abstract][Full Text] [Related]
16. Promyelocytic leukemia zinc finger protein activates GATA4 transcription and mediates cardiac hypertrophic signaling from angiotensin II receptor 2. Wang N; Frank GD; Ding R; Tan Z; Rachakonda A; Pandolfi PP; Senbonmatsu T; Landon EJ; Inagami T PLoS One; 2012; 7(4):e35632. PubMed ID: 22558183 [TBL] [Abstract][Full Text] [Related]
17. H- ras deletion protects against angiotensin II-induced arterial hypertension and cardiac remodeling through protein kinase G-Iβ pathway activation. Martín-Sánchez P; Luengo A; Griera M; Orea MJ; López-Olañeta M; Chiloeches A; Lara-Pezzi E; de Frutos S; Rodríguez-Puyol M; Calleros L; Rodríguez-Puyol D FASEB J; 2018 Feb; 32(2):920-934. PubMed ID: 29054855 [TBL] [Abstract][Full Text] [Related]
18. The estrogen receptor-alpha agonist 16alpha-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats. Pelzer T; Jazbutyte V; Hu K; Segerer S; Nahrendorf M; Nordbeck P; Bonz AW; Muck J; Fritzemeier KH; Hegele-Hartung C; Ertl G; Neyses L Cardiovasc Res; 2005 Sep; 67(4):604-12. PubMed ID: 15950203 [TBL] [Abstract][Full Text] [Related]
19. Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice. Liu Y; Gao L; Guo S; Liu Y; Zhao X; Li R; Yan X; Li Y; Wang S; Niu X; Yao L; Zhang Y; Li L; Yang H Cell Physiol Biochem; 2017; 43(6):2253-2263. PubMed ID: 29073623 [TBL] [Abstract][Full Text] [Related]
20. Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3β and TGF-β1-Smad signalling. Yan L; Wei X; Tang QZ; Feng J; Zhang Y; Liu C; Bian ZY; Zhang LF; Chen M; Bai X; Wang AB; Fassett J; Chen Y; He YW; Yang Q; Liu PP; Li H Cardiovasc Res; 2011 Oct; 92(1):85-94. PubMed ID: 21632881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]